Patent ID: 11897919
Assignee: GEOVAX, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 7:
8. A method for boosting an immune response to a human immunodeficiency virus (HIV) comprising administering to a human in need thereof a boost vaccination comprising:
a) an effective amount of a first modified vaccinia Ankara (MVA) vector encoding a membrane-bound HIV-1 envelope (Env) protein that, when expressed, is displayed on virus-like particles (VLPs), and,
b) an effective amount of a second MVA vector encoding an HIV-1 gp-140 protein,
wherein, prior to the administration of the boost vaccination, the human has previously been administered one or more prime vaccinations comprising a DNA vector encoding Gag-Pol and Env and one or more of Tat, Rev, Nef, Vif, Vpr, or Vpu HIV-1 antigens.